Works by Jambor, Ivan

Results: 56
    1

    Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00174-3
    By:
    • Leo, Patrick;
    • Janowczyk, Andrew;
    • Elliott, Robin;
    • Janaki, Nafiseh;
    • Bera, Kaustav;
    • Shiradkar, Rakesh;
    • Farré, Xavier;
    • Fu, Pingfu;
    • El-Fahmawi, Ayah;
    • Shahait, Mohammed;
    • Kim, Jessica;
    • Lee, David;
    • Yamoah, Kosj;
    • Rebbeck, Timothy R.;
    • Khani, Francesca;
    • Robinson, Brian D.;
    • Eklund, Lauri;
    • Jambor, Ivan;
    • Merisaari, Harri;
    • Ettala, Otto
    Publication type:
    Article
    2

    Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2734, doi. 10.3390/cancers14112734
    By:
    • Chakravarty, Dimple;
    • Ratnani, Parita;
    • Huang, Li;
    • Dovey, Zachary;
    • Sobotka, Stanislaw;
    • Berryhill, Roy;
    • Merisaari, Harri;
    • Al Shaarani, Majd;
    • Rai, Richa;
    • Jambor, Ivan;
    • Yadav, Kamlesh K.;
    • Mittan, Sandeep;
    • Parekh, Sneha;
    • Kodysh, Julia;
    • Wagaskar, Vinayak;
    • Brody, Rachel;
    • Cordon-Cardo, Carlos;
    • Rykunov, Dmitry;
    • Reva, Boris;
    • Davicioni, Elai
    Publication type:
    Article
    3
    4
    5
    6
    7

    Decipher Score predicts prostate specific antigen persistence after prostatectomy.

    Published in:
    Minerva Urology & Nephrology, 2023, v. 75, n. 5, p. 583, doi. 10.23736/S2724-6051.23.05395-8
    By:
    • TREACY, Patrick-Julien;
    • FALAGARIO, Ugo G.;
    • MAGNIEZ, François;
    • RATNANI, Parita;
    • WAJSWOL, Ethan;
    • MARTINI, Alberto;
    • JAMBOR, Ivan;
    • WIKLUND, Peter;
    • BENTELLIS, Imad;
    • BARTHE, Flora;
    • KYPRIANOU, Natasha;
    • DURAND, Matthieu;
    • STEFFENS, Daniel;
    • KARUNARATNE, Sascha;
    • LESLIE, Scott;
    • THANIGASALAM, Ruban;
    • TEWARi, Ash
    Publication type:
    Article
    8

    Using biomarkers in patients with positive multiparametric magnetic resonance imaging: 4Kscore predicts the presence of cancer outside the index lesion.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 1, p. 47, doi. 10.1111/iju.14385
    By:
    • Falagario, Ugo Giovanni;
    • Lantz, Anna;
    • Jambor, Ivan;
    • Martini, Alberto;
    • Ratnani, Parita;
    • Wagaskar, Vinayak;
    • Treacy, Patrick‐Julien;
    • Veccia, Alessandro;
    • Bravi, Carlo Andrea;
    • Bashorun, Hafis O;
    • Phillip, Deron;
    • Lewis, Sara;
    • Haines, Kenneth;
    • Cormio, Luigi;
    • Carrieri, Giuseppe;
    • Tewari, Ash
    Publication type:
    Article
    9

    Prediction of prostate cancer aggressiveness using 18F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66255-8
    By:
    • Movahedi, Parisa;
    • Merisaari, Harri;
    • Perez, Ileana Montoya;
    • Taimen, Pekka;
    • Kemppainen, Jukka;
    • Kuisma, Anna;
    • Eskola, Olli;
    • Teuho, Jarmo;
    • Saunavaara, Jani;
    • Pesola, Marko;
    • Kähkönen, Esa;
    • Ettala, Otto;
    • Liimatainen, Timo;
    • Pahikkala, Tapio;
    • Boström, Peter;
    • Aronen, Hannu;
    • Minn, Heikki;
    • Jambor, Ivan
    Publication type:
    Article
    10
    11
    12

    Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer.

    Published in:
    Cancer Reports, 2022, v. 5, n. 3, p. 1, doi. 10.1002/cnr2.1492
    By:
    • Beksac, Alp Tuna;
    • Ratnani, Parita;
    • Dovey, Zachary;
    • Parekh, Sneha;
    • Falagario, Ugo;
    • Roshandel, Reza;
    • Sobotka, Stanislaw;
    • Kewlani, Deepshikha;
    • Davis, Avery;
    • Weil, Rachel;
    • Bashorun, Hafis;
    • Jambor, Ivan;
    • Lewis, Sara;
    • Haines, Kenneth;
    • Tewari, Ashutosh K.
    Publication type:
    Article
    13

    Neuroimaging findings in 4342 hospitalized COVID‐19 subjects: A multicenter report from the United States and Europe.

    Published in:
    Journal of Neuroimaging, 2023, v. 33, n. 5, p. 752, doi. 10.1111/jon.13140
    By:
    • Faro, Scott H.;
    • Manmatharayan, Arichena;
    • Leiby, Benjamin;
    • Jain, Neelu;
    • Mohamed, Feroze B.;
    • Talekar, Kiran S.;
    • Doshi, Amish;
    • Jambor, Ivan;
    • Chang, Sanders;
    • Finkelstein, Mark;
    • Kremer, Stephane;
    • Lersy, Francois;
    • Lindgren, Brenden;
    • Figueiredo, Nathalia M.;
    • Gerevini, Simonetta;
    • Napolitano, Angela;
    • Jain, Rajan;
    • Dogra, Siddhanth;
    • Pillai, Jay J.;
    • Ryan, Dan
    Publication type:
    Article
    14
    15
    16
    17

    Plasma Pharmacokinetics, Whole-Body Distribution, Metabolism, and Radiation Dosimetry of <sup>68</sup>Ga Bombesin Antagonist BAY 86-7548 in Healthy Men.

    Published in:
    Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 867, doi. 10.2967/jnumed.112.114082
    By:
    • Roivainen, Anne;
    • Kähkönen, Esa;
    • Luoto, Pauliina;
    • Borkowski, Sandra;
    • Hofmann, Birte;
    • Jambor, Ivan;
    • Lehtiö, Kaisa;
    • Rantala, Tuija;
    • Rottmann, Antje;
    • Sipilä, Henri;
    • Sparks, Rick;
    • Suilamo, Sami;
    • Tolvanen, Tuula;
    • Valencia, Ray;
    • Minn, Heikki
    Publication type:
    Article
    18
    19

    Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.

    Published in:
    Journal of Magnetic Resonance Imaging, 2022, v. 55, n. 2, p. 465, doi. 10.1002/jmri.27811
    By:
    • Montoya Perez, Ileana;
    • Merisaari, Harri;
    • Jambor, Ivan;
    • Ettala, Otto;
    • Taimen, Pekka;
    • Knaapila, Juha;
    • Kekki, Henna;
    • Khan, Ferdhos L.;
    • Syrjälä, Elise;
    • Steiner, Aida;
    • Syvänen, Kari T.;
    • Verho, Janne;
    • Seppänen, Marjo;
    • Rannikko, Antti;
    • Riikonen, Jarno;
    • Mirtti, Tuomas;
    • Lamminen, Tarja;
    • Saunavaara, Jani;
    • Falagario, Ugo;
    • Martini, Alberto
    Publication type:
    Article
    20
    21
    22

    Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).

    Published in:
    2020
    By:
    • Perez, Ileana Montoya;
    • Jambor, Ivan;
    • Kauko, Tommi;
    • Verho, Janne;
    • Ettala, Otto;
    • Falagario, Ugo;
    • Merisaari, Harri;
    • Kiviniemi, Aida;
    • Taimen, Pekka;
    • Syvänen, Kari T.;
    • Knaapila, Juha;
    • Seppänen, Marjo;
    • Rannikko, Antti;
    • Riikonen, Jarno;
    • Kallajoki, Markku;
    • Mirtti, Tuomas;
    • Lamminen, Tarja;
    • Saunavaara, Jani;
    • Pahikkala, Tapio;
    • Boström, Peter J.
    Publication type:
    journal article
    23

    Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.

    Published in:
    2020
    By:
    • Montoya Perez, Ileana;
    • Jambor, Ivan;
    • Pahikkala, Tapio;
    • Airola, Antti;
    • Merisaari, Harri;
    • Saunavaara, Jani;
    • Alinezhad, Saeid;
    • Väänänen, Riina‐Minna;
    • Tallgrén, Terhi;
    • Verho, Janne;
    • Kiviniemi, Aida;
    • Ettala, Otto;
    • Knaapila, Juha;
    • Syvänen, Kari T.;
    • Kallajoki, Markku;
    • Vainio, Paula;
    • Aronen, Hannu J.;
    • Pettersson, Kim;
    • Boström, Peter J.;
    • Taimen, Pekka
    Publication type:
    journal article
    24
    25

    IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.

    Published in:
    2019
    By:
    • Merisaari, Harri;
    • Jambor, Ivan;
    • Ettala, Otto;
    • Boström, Peter J.;
    • Montoya Perez, Ileana;
    • Verho, Janne;
    • Kiviniemi, Aida;
    • Syvänen, Kari;
    • Kähkönen, Esa;
    • Eklund, Lauri;
    • Pahikkala, Tapio;
    • Vainio, Paula;
    • Saunavaara, Jani;
    • Aronen, Hannu J.;
    • Taimen, Pekka
    Publication type:
    journal article
    26
    27
    28
    29
    30

    Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

    Published in:
    2017
    By:
    • Ginsburg, Shoshana B.;
    • Algohary, Ahmad;
    • Pahwa, Shivani;
    • Gulani, Vikas;
    • Ponsky, Lee;
    • Aronen, Hannu J.;
    • Boström, Peter J.;
    • Böhm, Maret;
    • Haynes, Anne‐Maree;
    • Brenner, Phillip;
    • Delprado, Warick;
    • Thompson, James;
    • Pulbrock, Marley;
    • Taimen, Pekka;
    • Villani, Robert;
    • Stricker, Phillip;
    • Rastinehad, Ardeshir R.;
    • Jambor, Ivan;
    • Madabhushi, Anant;
    • Boström, Peter J
    Publication type:
    journal article
    31
    32
    33
    34

    Value of <sup>68</sup>Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [<sup>18</sup>F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study.

    Published in:
    European Radiology, 2023, v. 33, n. 1, p. 472, doi. 10.1007/s00330-022-08982-2
    By:
    • Beheshti, Mohsen;
    • Taimen, Pekka;
    • Kemppainen, Jukka;
    • Jambor, Ivan;
    • Müller, Andre;
    • Loidl, Wolfgang;
    • Kähkönen, Esa;
    • Käkelä, Meeri;
    • Berndt, Mathias;
    • Stephens, Andrew W.;
    • Minn, Heikki;
    • Langsteger, Werner
    Publication type:
    Article
    35
    36

    Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 9, p. 2951, doi. 10.1007/s00259-021-05296-1
    By:
    • Malaspina, Simona;
    • Anttinen, Mikael;
    • Taimen, Pekka;
    • Jambor, Ivan;
    • Sandell, Minna;
    • Rinta-Kiikka, Irina;
    • Kajander, Sami;
    • Schildt, Jukka;
    • Saukko, Ekaterina;
    • Noponen, Tommi;
    • Saunavaara, Jani;
    • Dean, Peter B.;
    • Sequeiros, Roberto Blanco;
    • Aronen, Hannu J.;
    • Kemppainen, Jukka;
    • Seppänen, Marko;
    • Boström, Peter J.;
    • Ettala, Otto
    Publication type:
    Article
    37

    Prospective evaluation of F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 3, p. 355, doi. 10.1007/s00259-017-3875-1
    By:
    • Jambor, Ivan;
    • Kuisma, Anna;
    • Kähkönen, Esa;
    • Kemppainen, Jukka;
    • Merisaari, Harri;
    • Eskola, Olli;
    • Teuho, Jarmo;
    • Perez, Ileana Montoya;
    • Pesola, Marko;
    • Aronen, Hannu J.;
    • Boström, Peter J.;
    • Taimen, Pekka;
    • Minn, Heikki
    Publication type:
    Article
    38

    Correlation between <sup>18</sup>F-1-amino-3-fluorocyclobutane-1-carboxylic acid (<sup>18</sup>F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.

    Published in:
    EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0518-5
    By:
    • Saarinen, Irena;
    • Jambor, Ivan;
    • Kim, Mai;
    • Kuisma, Anna;
    • Kemppainen, Jukka;
    • Merisaari, Harri;
    • Eskola, Olli;
    • Koskenniemi, Anna-Riina;
    • Perez, Ileana Montoya;
    • Boström, Peter;
    • Taimen, Pekka;
    • Minn, Heikki
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.

    Published in:
    Acta Oncologica, 2016, v. 55, n. 1, p. 59, doi. 10.3109/0284186X.2015.1027411
    By:
    • Jambor, Ivan;
    • Aronen, Hannu J.;
    • Kuisma, Anna;
    • Ramadan, Susan;
    • Huovinen, Riikka;
    • Minn, Heikki;
    • Sandell, Minna;
    • Auren, Joakim;
    • Saunavaara, Jani;
    • Kajander, Sami;
    • Kemppainen, Jukka;
    • Merisaari, Harri;
    • Seppänen, Marko;
    • Kauppila, Esa;
    • Noponen, Tommi
    Publication type:
    Article
    49
    50